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The mouse protection test for establishing the value of antipneumo- 
coccic serum does not give consistent results unless a  large number 
of mice are used.  Friedlander,  Sobotka  and Banzhaf  (1)  used  the 
specific polysaccharide of the pneumococcus  as an antigen for precipi- 
tation tests, to determine the potency of serum.  Their findings agreed 
fairly well with the mouse protection test of Felton (2). 
In confirming the work of Heidelberger and Avery (3), on the pneu- 
mococcus polysaccharide, we were struck by  the consistent results 
obtained in successive precipitation tests with any one serum.  At the 
same time, we have long been aware of the difficulty in the interpreta- 
tion of the mouse protection test in judging the potency of antipneumo- 
coccic serum.  We, therefore, have undertaken parallel studies on a 
series of antipneumococcic serums, using both the specific polysac- 
charide precipitation and mouse protection tests.  A close agreement 
between the results of the two methods was found to exist. 
The difficulty in the preparation of polysaccharide of the high purity 
obtained by Avery and Heidelberger would be a barrier to the practical 
routine  application  of  the  polysaccharide  precipitation  test.  We 
found,  however,  in  comparing different lots  of  polysaccharides  of 
varying purity, that results were comparable with each lot. 
Crude  polysaccharide prepared  by  the  following  technique  was 
found very satisfactory for use as antigen in the precipitation test: 
An 8 day broth culture of the type pneumococcus is evaporated to about one- 
fifteenth the original volume.  The material is  chilled  and  trichloracetic acid 
crystals added to make a  5 per cent solution.  A  precipitate is formed and re- 
moved by centrifugation as soon as possible.  To the clear supernatant about one 
and one-half volumes of alcohol are added and centrifuged.  The alcoholic pre- 
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cipitate contains the polysaccharide which is soluble in water and is purified by 
repeated re-precipitations with alcohol.  The final precipitation is usually done 
with acetone.  Further purification does not seem necessary. 
Polysaccharide made by this method when dried and dissolved in 
saline 1 to 10,000 can be satisfactorily  used for antigen in the precipita- 
tion test. 
The technique of the precipitation test used by us is as follows: Equal volumes 
of serum dilutions and a constant polysaccharide  dilution (1 to 10,000) are mixed 
and placed in a water bath at 37°C.  The water level should be not more than 
one-half that of the test mixture.  The test is read after 2 hours.  Further precipi- 
tation in higher dilutions may occur after longer incubation at 37°C., or a subse- 
quent period  on  ice,  but the result is not as clear cut, variations being more frequent 
than when the 2 hour reading is used. 
The interpretation of the test is based on a comparison of the titer 
of the complete precipitation of  a  standard  serum, F-146  (supplied 
by Felton), as containing 200 protective units* per cubic centimeter 
for Pneumococcus Types I  and  II,  with  that of the unknown test 
serum. 
In repeated tests, using a  solution of Type I  polysaccharide of 1 
to 10,000, the standard serum gave complete precipitation in a dilution 
of 1 to 20.  On this basis the number of units for Type I  of the test 
serum would be expressed by the following equation. 
Dilution of test serum 
X 200 =  Number of units of the test serum. 
20 
The results of comparative mouse protection and polysaccharide 
precipitation tests with a portion of the many polyvalent antipneumo- 
coccic Type I  and II serums,  tested,  are  shown in Table I.  Only 
results of tests with Type I  are given.  Type II values can also be 
tested by the polysaccharide precipitation test, the equation of calcula- 
tion, however, being  different as  the  standard  serum F-146 with a 
protective unit value of 200  units in Type II, results in a  complete 
precipitation at a dilution of 1:35 with the specific Type II polysac- 
charide used by us. 
* The standard value of this serum has recently been changed by Felton after 
testing with the different  strains of pneumococcus  used by the  various laboratories, 
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The interpretation of the mouse protection by direct calculation for 
unit value according to virulence is frequently difficult.  The varia- 
tions and irregularities in  the  time of  the  deaths frequently make 
necessary a  repetition of the test before results are obtained  which 
satisfactorily check with the established value of the standard serum. 
TABLE  I 
Type I  Antipneumococcus Protective Units Estimated by the Mouse Protection and 
Polysacckaride Precipitation Tests 
Serum  Mouse test  SSS Ppt. 
F-146 
7892 -N 
7879-A 
7895-G 
7899-M 
7900-H 
7905-I 
7908-I 
8081-A 
8082-A 
MM8843-A 
MM8843-B 
MM8843-C 
46130 
48398 
200 
100 
80 
200 
100 
50 
300 
300 
40 
50 
6OO 
100 
50 
50 
400 
200 
120 
80 
220 
100 
80 
300 
300 
50 
S0 
560 
90 
20 
50 
350 
* "SSS Ppt." is the designation used by Heidelberger and Avery for the "solu- 
ble specific substance"--polysaccharide responsible for the precipitate. 
The unit values given in Table I  are  therefore calculated by  direct 
comparison with the 200 unit standard serum F-146. 
Table II shows the results obtained with the polysaccharide precipi- 
tation and mouse  protection test, on using  serum  from consecutive 
bleedings from horses under immunization.  The protection test used 
in this series was that endorsed by the Hygienic Laboratory and con- 
trolled by their standard serum.  The serums are classified as good,fair 
or poor, according to the degree of protection, expressed in percentage, 
obtained in the group of mice placed on test.  The ease with which 
one can be misled by the use of the mouse test alone is shown.  For 
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3-15-30 is more accurately determined by the polysaccharide precipi- 
tation test.  The results of  tests on bleedings  which prove horses to 
be producing serum of a  higher value--such as Serum 7905--are con- 
sistent  with  the  mouse protection  test.  The  exact  status  of serum 
from horses on the borderline of productivity is much more accurately 
TABLE  II 
Antipneumococcic  Type I 
Protective Units in Consecutive Horse Bleedings 
I 
Date  SSS Ppt.  [  Mouse  Date  I  SSS Ppt.  Mouse 
Serum 7879  Serum 8083 
1-28-30 
2- 1-30 
2-15-30 
3- 7-30 
3-31-30 
1-30-30 
2-15-30 
3- 1-30 
3-15-30 
1-15-30 
1-30-30 
2-15-30 
3- 1-30 
90 
80 
50 
30 
30 
Fair 
Good 
Fair 
Poor 
Fair 
12-26-29 
1-26-30 
2-10-30 
3- 7-30 
3-15-30 
4- 1-30 
180 
100 
150 
80 
100 
80 
Serum789g  Serum8110 
180 
220 
100 
90 
12- 4-30 
1-30-30 
2-15-30 
3- 7-30 
3-22-30 
Good 
Fair 
Fair 
Fair 
240 
180 
30 
50 
Serum7905  Serum Sll3 
9-25-29 
12- 4-29 
1-30-30 
2-15-30 
3- 1-30 
200 
300 
280 
280 
180 
250 
280 
Good 
Good 
Good 
Good 
Fair 
Fair 
Fair 
Fair 
Fair 
Fair 
Poor 
Good 
Good 
Fair 
Fair 
Poor 
Fair 
Good 
Fair 
Good 
determined by the polysaccharide precipitin  test,  as  shown in bleed- 
ings of Serums 8083, 8110 and  8113. 
At present the immunization of all horses used in the production of 
anfipneumococcic serum is followed by means of the precipitation test. 
Mixtures of bleedings for concentration or other purposes, are checked 
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DISCUSSION 
The standardization of antipneumococcus serum Types I and II has 
been a very difficult problem on account of the variable results obtained 
with the mouse protection test.  The difference in the virulence of the 
cultures used, of Pneumococcus Types I and II makes comparison of 
the  mouse  tests  of  various  laboratories  impossible.  Even  within 
one laboratory, in  which the same strain  is  always used,  and with 
every care for absolute duplication of method and accuracy of tech- 
nique,  variations occur which often make the interpretation of the 
test difficult, and costly repetition necessary.  This is due to the very 
nature of the test, susceptibility of the mouse to a virulent pneumo- 
coccus being so marked that the smallest deviation in the number of 
organisms injected into the test animal leads to most confusing irregu- 
larity in the time of death.  Also variation in number of organisms is 
unavoidable  by  the  method because  of  the  procedure of  making 
dilutions as a basis for dosage. 
We  have  found  that  the  precipitation test is practical  and gives 
comparable  results  on  the repetition  of  tests.  Similar  conclusions 
have been reached by Heidelberger, Sia, and Kendall (see the following 
paper (4)). 
It seems highly probable that in the case of organisms elaborating 
specific polysaccharides this method of testing can be used for the 
standardization  of the antiserums.  We have  succeeded with  anti- 
anthrax serum, the  standardization of which has been  very unsatis- 
factory, and we are proceeding with tests of other antibacterial sera. 
CONCLUSIONS 
1.  The mouse protection test  used for the standardization of anti- 
pneumococcic serum Type I  and II is very unreliable. 
2.  The  specific polysaccharide precipitation  test  can  be  used  to 
establish the comparative value of a test serum to a standardized serum. 
3.  The polysaccharide used for such tests does not have to be of the 
highest purity. 476  ANTIPNELr~OCOCCIC SERUNI TYPES I  AND  II 
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